JP2010520251A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520251A5
JP2010520251A5 JP2009552166A JP2009552166A JP2010520251A5 JP 2010520251 A5 JP2010520251 A5 JP 2010520251A5 JP 2009552166 A JP2009552166 A JP 2009552166A JP 2009552166 A JP2009552166 A JP 2009552166A JP 2010520251 A5 JP2010520251 A5 JP 2010520251A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
halogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009552166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520251A (ja
JP4745446B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/052244 external-priority patent/WO2008107334A2/en
Publication of JP2010520251A publication Critical patent/JP2010520251A/ja
Publication of JP2010520251A5 publication Critical patent/JP2010520251A5/ja
Application granted granted Critical
Publication of JP4745446B2 publication Critical patent/JP4745446B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009552166A 2007-03-05 2008-02-25 Glyt−1阻害剤の合成 Active JP4745446B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07103485 2007-03-05
EP07103485.4 2007-03-05
PCT/EP2008/052244 WO2008107334A2 (en) 2007-03-05 2008-02-25 Process for the synthesis of glyt-1 inhibitors

Publications (3)

Publication Number Publication Date
JP2010520251A JP2010520251A (ja) 2010-06-10
JP2010520251A5 true JP2010520251A5 (https=) 2010-12-09
JP4745446B2 JP4745446B2 (ja) 2011-08-10

Family

ID=39469606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009552166A Active JP4745446B2 (ja) 2007-03-05 2008-02-25 Glyt−1阻害剤の合成

Country Status (13)

Country Link
US (1) US7812161B2 (https=)
EP (1) EP2131843B1 (https=)
JP (1) JP4745446B2 (https=)
KR (1) KR101143073B1 (https=)
CN (1) CN101622000B (https=)
AT (1) ATE532516T1 (https=)
AU (1) AU2008223915B2 (https=)
BR (1) BRPI0808570B8 (https=)
CA (1) CA2678630C (https=)
ES (1) ES2375585T3 (https=)
IL (1) IL200323A (https=)
MX (1) MX2009009065A (https=)
WO (1) WO2008107334A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5656474B2 (ja) 2010-06-28 2015-01-21 関東化学株式会社 脂肪族光学活性フルオロアルコールの製造方法
CN104628679B (zh) * 2013-11-08 2018-02-09 江苏恩华药业股份有限公司 Bitopertin的合成方法及其中间体
CN106397312B (zh) * 2015-07-31 2020-03-24 广东东阳光药业有限公司 一种制备glyt-1抑制剂的方法
KR20220125326A (ko) 2020-01-09 2022-09-14 디스크 메디슨, 인크. 적혈구형성 프로토포르피린증, x-연계된 프로토포르피린증, 또는 선천성 적혈구 조혈포르피린증을 글리신 운반 억제제로 치료하는 방법
CA3195702A1 (en) 2020-10-13 2022-04-21 Boehringer Ingelheim International Gmbh Process of reworking
WO2024042043A1 (en) 2022-08-24 2024-02-29 Boehringer Ingelheim International Gmbh A scalable process for the preparation of a glyt-1 inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
US4480102A (en) * 1982-07-23 1984-10-30 The Dow Chemical Company 2,3-Difluoro-5-(trifluoromethyl)pyridine and methods of making and using the same
DE68912282T2 (de) * 1988-11-24 1994-04-28 Akzo Nv 1-[Mono- oder bis(trifluormethyl)-2-pyridinyl]piperazine enthaltende pharmazeutische Zusammensetzungen.
DE4235155A1 (de) * 1992-10-19 1994-04-21 Basf Ag Verfahren zur Herstellung von Methylsulfonylbenzoesäuren
US6384080B1 (en) * 1998-04-20 2002-05-07 Fujisawa Pharmaceutical Co., Ltd. Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase
DE10112040A1 (de) * 2001-03-14 2002-10-02 Aventis Pharma Gmbh Verbessertes Verfahren zur Herstellung von Sulfonylcarboxamidderivaten
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
RS53252B (sr) * 2003-08-11 2014-08-29 F.Hoffmann-La Roche Ag. Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1
HRP20090264T1 (hr) * 2004-12-09 2009-06-30 F. Hoffmann - La Roche Ag Derivati fenil-piperazin metanona
CA2593453A1 (en) * 2005-01-06 2006-07-13 F. Hoffmann-La Roche Ag Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
AU2005324024B2 (en) * 2005-01-07 2011-02-17 F. Hoffmann-La Roche Ag [4-(Heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
CN101218350B (zh) * 2005-07-08 2011-08-31 弗·哈夫曼-拉罗切有限公司 1,1,1-三氟丙酮的不对称还原反应

Similar Documents

Publication Publication Date Title
JP2010520251A5 (https=)
JP2010531876A5 (https=)
JP2008063319A5 (https=)
JP2006519818A5 (https=)
JP2012506425A5 (https=)
JP2010513494A5 (https=)
JP2010526056A (ja) イマチニブの製造方法
RU2016124160A (ru) Процессы приготовления производных соединений дигидропиримидина и их промежуточных продуктов
JP2009515988A5 (https=)
JP2014532054A5 (https=)
JP2006528980A5 (https=)
JP2012526086A5 (https=)
JP2009527517A5 (https=)
JP2013520495A5 (https=)
CN106831737B (zh) 维帕他韦及其衍生物的制备
JP2005516030A5 (https=)
JP2008520662A5 (https=)
JP2006526587A5 (https=)
CN102516550A (zh) 七元瓜环-稀土金属线性管状超分子聚合物及制备和应用
CN101857559B (zh) 手性α-(三氯甲基)胺类化合物及其制备方法
CN102675181B (zh) 一种左乙拉西坦的制备方法
JP2007506659A5 (https=)
JP2007045816A5 (ja) カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法
JP2011513358A5 (https=)
JP6228210B2 (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法